$2.33 -0.08 (-3.32%)
2/10/2012 4:00 PM

MannKind Corp (NASDAQ:MNKD)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Featured Broker Partners


Advertisement